DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor

Ke Li1, Shuqing Zhao, Vinit Karur

  • 1Immunobiology Program and the Department of Veterinary Science, Pennsylvania State University, University Park, Pennsylvania 16802, USA.

Insights

This study reveals key roles for the DYRK3 kinase, particularly its YTY motif, in activating kinase function and influencing hematopoietic progenitor cell survival. It also details DYRK3

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Hematopoiesis

Background:

  • DYRKs (Dual-specificity Tyrosine-Regulated Kinases) are emerging as critical regulators of cell growth and development.
  • DYRK3 is specifically expressed in erythroid progenitor cells and impacts late-stage erythropoiesis.
  • Understanding DYRK3's precise mechanisms and functions is crucial for deciphering its role in cellular processes.

Purpose of the Study:

  • To elucidate the role of the DYRK3 YTY signature motif in kinase activation.
  • To investigate the interaction between DYRK3 and the cAMP response element (CRE)-binding protein (CREB).
  • To determine the effects of DYRK3 on hematopoietic progenitor cell survival.

Main Methods:

  • Site-directed mutagenesis was used to analyze the DYRK3 YTY motif and kinase domain.
  • Luciferase reporter assays and Western blotting were employed to assess CREB activation and phosphorylation.
  • DYRK3 expression was manipulated in hematopoietic cell lines to evaluate effects on cell survival.

Main Results:

  • The intactness of Tyr(333) in the DYRK3 kinase domain is critical for activation, while Tyr(331) and Tyr(333) acidification leads to constitutive activation.
  • DYRK3 efficiently stimulates CRE-luciferase expression, activates CREB, and promotes CREB phosphorylation at Ser(133), with partial support from kinase-inactive mutants and C-terminal regions, suggesting interplay with Protein Kinase A.
  • DYRK3 expression inhibits programmed cell death in hematopoietic progenitor cells.

Conclusions:

  • DYRK3 kinase activity and activation are modulated by specific tyrosine residues within its kinase domain.
  • DYRK3 signaling pathways involve the CREB/CRE pathway and potentially interact with Protein Kinase A.
  • DYRK3 plays a significant role in promoting hematopoietic progenitor cell survival, highlighting its potential biofunctions.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...